Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide.
D000120:Acecainide / Q000009:adverse effects* / Q000097:blood; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects; D002467:Cell Nucleus / Q000276:immunology; D004247:DNA / Q000276:immunology; D004277:DNA, Single-Stranded / Q000276:immunology; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D011342:Procainamide / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000097:blood
D000974:Antibodies, Antinuclear; D004277:DNA, Single-Stranded; D004247:DNA; D000120:Acecainide; D011342:Procainamide